Literature DB >> 28251499

Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases.

Nobuyuki Asato1, Masakatsu Tsurusaki2,3, Keitaro Sofue4,5, Yoko Hieda6, Takashi Katsube6, Kazuhiro Kitajima7, Takamichi Murakami1.   

Abstract

PURPOSE: To evaluate the diagnostic efficacy of gadoxetic acid-enhanced magnetic resonance imaging (EOB-MRI) vs. contrast-enhanced computed tomography (CE-CT) in the detection of liver metastasis in colorectal carcinoma patients.
MATERIALS AND METHODS: One-hundred fifty-eight consecutive patients with histopathologically confirmed colorectal carcinoma underwent EOB-MRI and CE-CT; 68 patients had 105 surgically confirmed liver metastases. Diagnostic analyses were performed according to sensitivity and positive predictive value (PPV) for liver metastasis detection in combined arterial- and hepatocyte-phase images vs. CE-CT by three readers blinded to clinical data. Diagnostic accuracy and sensitivity were evaluated using the alternative free-response receiver operating characteristic method.
RESULTS: The overall sensitivity of EOB-MRI (91.4%) was significantly higher than that of CE-CT (80.9%, p < 0.001); the higher sensitivity of EOB-MRI was observed especially in smaller-sized lesions (73.3 vs. 56.0% for lesions ≤1 cm; 91.9 vs. 80.8% for lesions >1 cm and ≤2 cm; 99.2 vs. 95.7% for lesions >2 cm). EOB-MRI showed a significantly greater area under the receiver operating characteristic curve (Az value = 0.970) compared with CE-CT (Az value = 0.899, p < 0.01).
CONCLUSION: EOB-MRI provided higher detectability for liver metastases, especially for smaller-sized lesions, than CE-CT in patients with colorectal carcinoma.

Entities:  

Keywords:  Gadoxetic acid; Liver; Magnetic resonance imaging; Multidetector computed tomography; Neoplasm metastasis

Mesh:

Substances:

Year:  2017        PMID: 28251499     DOI: 10.1007/s11604-017-0622-2

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  35 in total

Review 1.  Abdominal magnetic resonance imaging at 3.0 T: problem or a promise for the future?

Authors:  Shahid M Hussain; Piotr A Wielopolski; Diego R Martin
Journal:  Top Magn Reson Imaging       Date:  2005-07

2.  Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.

Authors:  Chusilp Charnsangavej; Bryan Clary; Yuman Fong; Axel Grothey; Timothy M Pawlik; Michael A Choti
Journal:  Ann Surg Oncol       Date:  2006-09-01       Impact factor: 5.344

3.  Quantitative and qualitative comparison of 3.0T and 1.5T MR imaging of the liver in patients with diffuse parenchymal liver disease.

Authors:  Masakatsu Tsurusaki; Richard C Semelka; Mauricio Zapparoli; Jorge Elias; Ersan Altun; Ertan Pamuklar; Kazuro Sugimura
Journal:  Eur J Radiol       Date:  2008-09-13       Impact factor: 3.528

4.  Statistical comparison of two ROC-curve estimates obtained from partially-paired datasets.

Authors:  C E Metz; B A Herman; C A Roe
Journal:  Med Decis Making       Date:  1998 Jan-Mar       Impact factor: 2.583

5.  Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.

Authors:  J Ward; K S Naik; J A Guthrie; D Wilson; P J Robinson
Journal:  Radiology       Date:  1999-02       Impact factor: 11.105

6.  High-field-strength MR imaging of the liver at 3.0 T: intraindividual comparative study with MR imaging at 1.5 T.

Authors:  Marcus M von Falkenhausen; Götz Lutterbey; Nuschin Morakkabati-Spitz; Oliver Walter; Jürgen Gieseke; Renate Blömer; Winfried A Willinek; Hans H Schild; Christiane K Kuhl
Journal:  Radiology       Date:  2006-08-14       Impact factor: 11.105

7.  Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.

Authors:  Carlo Bartolozzi; Francescamaria Donati; Dania Cioni; Carlo Procacci; Giovanni Morana; Antonio Chiesa; Luigi Grazioli; Giorgio Cittadini; Giuseppe Cittadini; Andrea Giovagnoni; Giovanni Gandini; Jochen Maass; Riccardo Lencioni
Journal:  Eur Radiol       Date:  2003-08-09       Impact factor: 5.315

8.  Detection of liver metastasis: is diffusion-weighted imaging needed in Gd-EOB-DTPA-enhanced MR imaging for evaluation of colorectal liver metastases?

Authors:  Taku Tajima; Masaaki Akahane; Hidemasa Takao; Hiroyuki Akai; Shigeru Kiryu; Hiroshi Imamura; Yasushi Watanabe; Norihiro Kokudo; Kuni Ohtomo
Journal:  Jpn J Radiol       Date:  2012-07-18       Impact factor: 2.374

Review 9.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

Authors:  Christoph J Zech; Karin A Herrmann; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

10.  Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.

Authors:  Hye Jin Kim; Seung Soo Lee; Jae Ho Byun; Jin Cheon Kim; Chang Sik Yu; Seong Ho Park; Ah Young Kim; Hyun Kwon Ha
Journal:  Radiology       Date:  2014-10-03       Impact factor: 11.105

View more
  7 in total

1.  Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.

Authors:  Kim Sivesgaard; Lars P Larsen; Michael Sørensen; Stine Kramer; Sven Schlander; Nerijus Amanavicius; Arindam Bharadwaz; Dennis Tønner Nielsen; Frank Viborg Mortensen; Erik Morre Pedersen
Journal:  Eur Radiol       Date:  2018-05-07       Impact factor: 5.315

2.  Detection of liver metastases on gadobenate dimeglumine-enhanced MRI: systematic review, meta-analysis, and similarities with gadoxetate-enhanced MRI.

Authors:  Ling Zhang; Xian Yu; Lei Huo; Lun Lu; Xinpeng Pan; Ningyang Jia; Xinxiang Fan; Giovanni Morana; Luigi Grazioli; Guenther Schneider
Journal:  Eur Radiol       Date:  2019-03-26       Impact factor: 5.315

3.  Utility of Stack-of-stars Acquisition for Hepatobiliary Phase Imaging without Breath-holding.

Authors:  Shintaro Ichikawa; Utaroh Motosugi; Marie-Luise Kromrey; Daiki Tamada; Tetsuya Wakayama; Kang Wang; Ty A Cashen; Ali Ersoz; Hiroshi Onishi
Journal:  Magn Reson Med Sci       Date:  2019-05-07       Impact factor: 2.471

4.  Optimal Combination of Features on Gadoxetate Disodium-enhanced MR Imaging for Non-invasive Differential Diagnosis of Hepatocellular Carcinoma: The JAMP-HCC Study.

Authors:  Shintaro Ichikawa; Utaroh Motosugi; Hiroyuki Morisaka; Kazuto Kozaka; Satoshi Goshima; Tomoaki Ichikawa
Journal:  Magn Reson Med Sci       Date:  2020-02-27       Impact factor: 2.471

5.  Diagnostic Value of Delayed PET/MR in Liver Metastasis in Comparison With PET/CT.

Authors:  Nina Zhou; Xiangxi Meng; Yan Zhang; Boqi Yu; Jianmin Yuan; Jiangyuan Yu; Hua Zhu; Zhi Yang
Journal:  Front Oncol       Date:  2021-08-30       Impact factor: 6.244

6.  Whole-liver enhanced CT radiomics analysis to predict metachronous liver metastases after rectal cancer surgery.

Authors:  Meng Liang; Xiaohong Ma; Hongmei Zhang; Xinming Zhao; Leyao Wang; Dengfeng Li; Sicong Wang
Journal:  Cancer Imaging       Date:  2022-09-11       Impact factor: 5.605

Review 7.  The Value of 18F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review.

Authors:  Okker D Bijlstra; Maud M E Boreel; Sietse van Mossel; Mark C Burgmans; Ellen H W Kapiteijn; Daniela E Oprea-Lager; Daphne D D Rietbergen; Floris H P van Velden; Alexander L Vahrmeijer; Rutger-Jan Swijnenburg; J Sven D Mieog; Lioe-Fee de Geus-Oei
Journal:  Diagnostics (Basel)       Date:  2022-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.